Swarms of locusts trigger panic in Dakshina Kannada

Bengaluru, Jun 23: Karnataka Congress leader and Kanakapura MLA DK Shivakumar said on Monday that in the wake of coronavirus pandemic, people of his assembly constituency have taken a unanimous decision of remaining under voluntary lockdown until July 1.

The decision was taken after he headed a meeting at Kanakapura on Sunday, at the office of Kanakapura Municipality.

"Let us consider the situation after July 1, hold a similar meeting, and take the next decision. It has nothing to do with the state government's mandate. It came to the conclusion that this was a decision that we all voluntarily took," said DK Shivakumar.

DK Shivakumar informed that the merchants have agreed to sell groceries, fruits, vegetables, fennel, meat and other food items from 7 a.m. to 11 p.m. only. District authorities, DCs, SPs and hospital representatives have decided the timings of clinics and drug stores.

He further said, "In this self-motivated lockdown, unnecessary driving should be avoided. The social gap must be maintained. No one should be oppressed by anyone."

Member of Parliament DK Suresh, Ravi - Ramanagara District Collector Archana, SP Anoop Shetty, and Kanakapura Planning Authority Chairman Jagannath were also present in the meeting.

Mangaluru, June 21: A gang of miscreants intercepted a goods auto-rickshaw which was legally transporting beef from an abattoir to market and attacked its driver in heart of the city this morning. 

The attack comes exactly a week after a gang of Bajrang Dal miscreants thrashed a cattle trader at Urwa while legally transporting four buffalos to Kudroli abattoir on June 13.

Today, a person identified as Abdul Rasheed was transporting around 200 kilograms of beef from Kudroli abattoir to Kankanady market.

Meanwhile, miscreants began to chase beef laden vehicle and managed to waylay it near Highland Hospital. They thrashed Abdul Rasheed and poured kerosene on the beef besides damaging the vehicle. 

The miscreants fled in their car and motorbikes after passersby began to gather. 

Bengaluru, Mar 27: Oncologist Dr. Vishal Rao, HCG Hospital Bengaluru on Friday said that human body cells release interferon chemical to kill viruses but it cannot be released by cells in the case of COVID-19 cases, leading to weak immune system. However, a therapy of specific concoction could be useful in treating COVID-19 patients.

"We got hold of some preprint suggesting that interferon is effective in COVID19," said Rao.

Speaking to news agency, he continued saying "When we withdraw blood for regular check-ups, we get buffy coat which can be used to take out cells and form interferon. These two chemicals and some other cytokines, in a specific concoction, could be potentially very useful in treating COVID-19 patients."

Rao said that they have built a concoction of cytokines which can be injected to reactivate immune system in COVID-19 patients.

"We are in a very initial stage and hope to be ready with its first set by this weekend. We have applied to the governement for an expedited review. We have also presented this before the state government" said Rao.

"We have a team of infection specialist, ICU team and other...all of us have worked together to build something that we believe. We want to serve the society at this hour of need," he added.

Dr Rao clarified that this is not a vaccine and this particular interferon therapy does not help to prevent the infection of COVID-19. However, this is focused and targeted towards COVID-19 positive patients or those who have just incubated the virus.

"We believe that in early stages as well as the patients who have just incubated, this particular therapy of interferon gama and other concoction of cytokines could be an effective method. In the late stages we are looking at specific dosage of the cells which are our own body cells which can actually be affective and could also be of use for the ventilator patients," he added.

Meanwhile, Dr Gururaj, Immunologist and Scientist told ANI that they are trying to cover two aspects, one is the early stage patients where they are trying to improve their immune systems.

"As Dr Vishal said, we are trying to see whether we can use the cytokines from our own immune cells which is a natural process but it is hampered in infected patients," said Dr Gururaj.

"In the last phase we are using cells which are used from the bone marrow of the patient or donors. We can use those cells to reduce the inflation and so called cytokines release syndrome which is basically the inflammatory response of the body," he added.